Navigation Links
JoVE partners with US government to publish cutting-edge defense research
Date:5/15/2012

On May 15, 2012, JoVE (Journal of Visualized Experiments) will publish two articles in partnership with the United States government's Defense Threat Reduction Agency (DTRA). JoVE is proud to present the work from Temple University's Dr. Chris Schafmeister and State University of New York Buffalo's Dr. David Pawlowski and Dr. Richard Karalus.

The support of scientists conducting research for DTRA has significant ramifications for identifying, treating, and preventing the outbreak of defense threats. DTRA exists to safeguard America and its allies from weapons of mass destruction (WMD), including chemical, biological, radiological, nuclear weapons and high-yield explosives (CBRNE), by providing capabilities to reduce, eliminate, and counter the threat and mitigate its effects. Because the techniques and technologies developed in DTRA sponsored laboratories promise a safer world and will benefit from distribution in a highly visual format, DTRA has sponsored the research and publication of their scientists in JoVE.

From Temple University, award winning scientist Dr. Chris Schafmeister, working with Conrad Pfeiffer, developed a biochemical technique that produces new, complex polymers called bis-peptides. Dr. Schafmeister tells us, "The building blocks and the final molecule are special. Our molecules bind with two bonds to each molecule, unlike the typical single bond, making a stiff, ladder-like construct." Dr. Schafmeister won the "Outstanding Scientific Achievement Award" from the Chemical and Biological Defense Science and Technology conference for his work. Dr. Schafmeister, choosing to publish his research in JoVE, notes, "This procedure demonstrates cutting edge capabilities that don't exist anywhere else. Hopefully, they will lead to products in the next decade far beyond anything we can produce right now."

In the second DTRA sponsored JoVE article, Dr. David Pawlowski and his colleague Dr. Richard Karalus publish their procedure on the isolation of nucleic acids and proteins, without electricity or laboratory support. This work has significant implications for real time threat monitoring. Dr. Pawlowski explains, "This is a handheld electricity-free device which can be used in the field by the warfighter, in conjunction with their detection platforms." He continues, stating that this technique will "be useful for detection of typical biological warfare agents." Dr. Pawlowski notes that he and his colleagues were incredibly satisfied with their experience publishing in this format. "My reason for publishing this in JoVE is that a video article offered us the opportunity to provide a visualization of this small, handheld tool. Giving a simple, verbal description is difficult, so a JoVE publication helps with training the warfighters how to use the technique."

JoVE is proud to work with these unique scientists and to support DTRA's mission. Dr. Nandita Singh, Senior Science Editor at JoVE, attended the annual Chemical and Biological Defense Science and Technology Conference, this past November, where she encountered the wide variety of research funded by DTRA. She notes, "The research funded by DTRA is very cutting edge and exciting. I look forward to our partnership because the JoVE format will allow the scientific community to accurately replicate the methodologies developed by DTRA funding. This partnership poses a unique opportunity for JoVE to help support military services and their allies in an effort to promote counterproliferation, nonproliferation and WMD reduction issues. Carl Brown Sr., DTRA Staff Director for Strategic Communication & Outreach says, for DTRA, this partnership is ideal, as "it is essential that the national security and scientific communities leverage efforts and activities to maximize global health security."


'/>"/>

Contact: Neal Moawed
neal.moawed@jove.com
617-245-0137
The Journal of Visualized Experiments
Source:Eurekalert  

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
3. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
4. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
5. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
6. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
7. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
8. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
9. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
10. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
11. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
JoVE partners with US government to publish cutting-edge defense research
(Date:3/27/2017)... DIEGO , March 27, 2017  Trovagene, Inc. ... that its Chief Executive Officer, Bill Welch , ... April 4, 2017 at 9:00 AM EDT at the ... .  Bill Welch, and Chief Scientific Officer, Mark ... with investors during the conference.   The presentation ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Human ... report to their offering. ... This report analyzes the Global market for Human Embryonic ... are provided for the period 2014 through 2022. Market data and ... The report profiles 25 companies including many key and niche players ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
Breaking Biology Technology:
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):